Search Results - "Findlay, Steven"

Refine Results
  1. 1

    Consumers' Interest In Provider Ratings Grows, And Improved Report Cards And Other Steps Could Accelerate Their Use by Findlay, Steven D

    Published in Health Affairs (01-04-2016)
    “…Encouraging patients and consumers to use data and other information in choosing health care providers is an important way to enhance patient engagement and…”
    Get full text
    Journal Article
  2. 2

    Mapping global and local coevolution across 600 species to identify novel homologous recombination repair genes by Sherill-Rofe, Dana, Rahat, Dolev, Findlay, Steven, Mellul, Anna, Guberman, Irene, Braun, Maya, Bloch, Idit, Lalezari, Alon, Samiei, Arash, Sadreyev, Ruslan, Goldberg, Michal, Orthwein, Alexandre, Zick, Aviad, Tabach, Yuval

    Published in Genome research (01-03-2019)
    “…The homologous recombination repair (HRR) pathway repairs DNA double-strand breaks in an error-free manner. Mutations in HRR genes can result in increased…”
    Get full text
    Journal Article
  3. 3

    Provider Perspectives of Patient Experiences in Primary Care Imaging by Zigman Suchsland, Monica L, Hardy, Victoria, Zhang, Ying, Vigil, Patrick D, Collins, Kimberly L, Woodhouse, William M, Chou, Roger, Findlay, Steven D, Lavallee, Danielle C, Thompson, Matthew J

    “…Imaging tests are a widely used tool in primary care with many known benefits. Without an understanding of which outcomes matter the most to patients,…”
    Get full text
    Journal Article
  4. 4

    Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers by Findlay, S D

    Published in PharmacoEconomics (2001)
    “…Spending on outpatient prescription drugs in the US is accelerating rapidly. Although numerous factors are driving this trend, attention has recently focused…”
    Get full text
    Journal Article
  5. 5

    Bringing The DERP To Consumers: 'Consumer Reports Best Buy Drugs' by Findlay, Steven D

    Published in Health Affairs (01-07-2006)
    “…Consumers Union, publisher of Consumer Reports magazine, has used the drug class reviews of the Drug Effectiveness Review Project (DERP) as one critical…”
    Get full text
    Journal Article
  6. 6

    PERSPECTIVE: Bringing The DERP To Consumers: 'Consumer Reports Best Buy Drugs' by Findlay, Steven D

    Published in Health affairs (Millwood, Va.) (01-07-2006)
    “…Consumers Union, publisher of Consumer Reports magazine, has used the drug class reviews of the Drug Effectiveness Review Project (DERP) as one critical…”
    Get full text
    Journal Article
  7. 7

    3157 – GENOME-WIDE CRISPR SCREENING IDENTIFIES THE MITOCHONDRIAL PYRUVATE CARRIER AS A MODULATOR OF BORTEZOMIB IN MULTIPLE MYELOMA by Orthwein, Alexandre, Findlay, Steven

    Published in Experimental hematology (2022)
    “…Proteasome inhibitors, including the FDA-approved bortezomib (BTZ), are frequently used for the treatment of patients affected by multiple myeloma (MM)…”
    Get full text
    Journal Article
  8. 8

    Consumers And Quality-Driven Health Care: A Call To Action by Shaller, Dale, Sofaer, Shoshanna, Findlay, Steven D, Hibbard, Judith H, Lansky, David, Delbanco, Suzanne

    Published in Health Affairs (01-03-2003)
    “…A key strategy for driving improvements in health care quality is providing comparative quality information to consumers. This strategy will not work, and…”
    Get full text
    Journal Article
  9. 9

    An E3 ubiquitin ligase localization screen uncovers DTX2 as a novel ADP-ribosylation-dependent regulator of DNA double-strand break repair by Djerir, Billel, Marois, Isabelle, Dubois, Jean-Christophe, Findlay, Steven, Morin, Théo, Senoussi, Issam, Cappadocia, Laurent, Orthwein, Alexandre, Maréchal, Alexandre

    Published in The Journal of biological chemistry (01-08-2024)
    “…DNA double-strand breaks (DSBs) elicit an elaborate response to signal damage and trigger repair via two major pathways: nonhomologous end-joining (NHEJ),…”
    Get full text
    Journal Article
  10. 10

    Identification of Novel Therapeutic Vulnerabilities in Multiple Myeloma by Findlay, Steven

    Published 01-01-2022
    “…Multiple myeloma (MM) is one of the most common hematological malignancies in the western world, with an incidence rate that has increased over the last 20…”
    Get full text
    Dissertation
  11. 11
  12. 12
  13. 13

    Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: A dose-response study by Aaronson, Donald, Kaiser, Harold, Dockhorn, Robert, Findlay, Steven, Korenblat, Philip, Thorsson, Lars, Källén, Anders

    Published in Journal of allergy and clinical immunology (01-03-1998)
    “…Background: As a general phenomenon, corticosteroids may suppress the activity in the hypothalamic-pituitary-adrenal (HPA) axis. The adrenal stimulation test…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis by Vargas, Ramón, Dockhorn, Robert J., Findlay, Steven R., Korenblat, Phillip E., Field, Elizabeth A., Kral, Kenneth M.

    Published in Journal of allergy and clinical immunology (01-08-1998)
    “…Background: Fluticasone propionate is a glucocorticoid with negligible oral bioavailability and very low intranasal bioavailability that is used as an…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis by GROSSMAN, J, BANOV, C, FIELD, E. A, ROGENES, P. R, BRONSKY, R. A, NATHAN, R. A, PEARLMAN, D, WINDER, J. A, RATNER, P. H, MENDELSON, L, FINDLAY, S. R, KRAL, K. M

    Published in Pediatrics (Evanston) (01-10-1993)
    “…Fluticasone propionate aqueous nasal spray, a new topical corticosteroid preparation, is effective when given as 200 micrograms once daily in patients (> 12…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Managed behavioral health care in 1999: an industry at a crossroads by Findlay, S

    Published in Health affairs (Millwood, Va.) (01-09-1999)
    “…From a few fledgling initiatives in the early 1980s in California, managed care has grown to a $4.4 billion industry, covering 176.8 million people in the US…”
    Get full text
    Journal Article